Investing.com - Pfizer (NYSE:PFE) reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.78 on revenue of $13.3B. Analysts polled by Investing.com expected EPS of $0.75 on revenue of $13.55B. That compared to EPS of $0.67 on revenue of $12.90B in the same period a year earlier. The company had reported EPS of $0.81 on revenue of $13.47B in the previous quarter.
For the year, Pfizer shares are up 19.35%, outperforming the S&P Global (NYSE:SPGI) 100 which is down 3.51% year to date.
Pfizer follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.05B.
Novartis ADR earnings beat analyst's expectations on October 18, with third quarter EPS of $1.32 on revenue of $12.78B. Investing.com analysts expected EPS of $1.3 on revenue of $12.94B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar